Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized anti-human NKG2A monoclonal antibody

Humanized anti-human NKG2A monoclonal antibody

US Patent 9422368 · Granted Aug 23, 2016

Estimated economic value: $25,161,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide immunogens and formulations thereof targeting membrane-bound IgE for tre2025
Oxazolidinone compounds and methods of use thereof as antibacterial agents2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
Antibody binding to human HER2 and preparation method and use thereof2025
Spirotricycle RIPK1 inhibitors and methods of uses thereof2024
Procoagulant antibodies2024
TrkA antibody and application thereof2024
Chromane amidine monobactam compounds for the treatment of bacterial infections2024
Benzimidazoles and indoles as taro inhibitors2023
Oxazolidinones as TarO inhibitors2023
Anti-PD-1 monoclonal antibody, and preparation method therefor and application t2022
Procoagulant antibodies2022